Literature DB >> 25348469

Nattokinase: production and application.

Fatemeh Dabbagh1, Manica Negahdaripour, Aydin Berenjian, Abdolazim Behfar, Fatemeh Mohammadi, Mozhdeh Zamani, Cambyz Irajie, Younes Ghasemi.   

Abstract

Nattokinase (NK, also known as subtilisin NAT) (EC 3.4.21.62) is one of the most considerable extracellular enzymes produced by Bacillus subtilis natto. The main interest about this enzyme is due to its direct fibrinolytic activity. Being stable enough in the gastrointestinal tract makes this enzyme a useful agent for the oral thrombolytic therapy. Thus, NK is regarded as a valuable dietary supplement or nutraceutical. Proven safety and ease of mass production are other advantages of this enzyme. In addition to these valuable advantages, there are other applications attributed to NK including treatment of hypertension, Alzheimer's disease, and vitreoretinal disorders. This review tends to bring a brief description about this valuable enzyme and summarizes the various biotechnological approaches used in its production, recovery, and purification. Some of the most important applications of NK, as well as its future prospects, are also discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25348469     DOI: 10.1007/s00253-014-6135-3

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  25 in total

Review 1.  Microbial production of nattokinase: current progress, challenge and prospect.

Authors:  Dongbo Cai; Chengjun Zhu; Shouwen Chen
Journal:  World J Microbiol Biotechnol       Date:  2017-04-04       Impact factor: 3.312

2.  Designing a less immunogenic nattokinase from Bacillus subtilis subsp. natto: a computational mutagenesis.

Authors:  Yoanes Maria Vianney; Stanley Evander Emeltan Tjoa; Reza Aditama; Sulisyto Emantoko Dwi Putra
Journal:  J Mol Model       Date:  2019-11-09       Impact factor: 1.810

Review 3.  Purification, biochemical characterization and fibrinolytic potential of proteases produced by bacteria of the genus Bacillus: a systematic literature review.

Authors:  Arthur Hipólito Pereira Leite; Ítalo Henrique Alves da Silva; Lorenzo Pastrana; Thiago Pajeú Nascimento; Adriana Maria da Silva Telles; Ana Lúcia Figueiredo Porto
Journal:  Arch Microbiol       Date:  2022-07-19       Impact factor: 2.667

4.  High and Economical Nattokinase Production with Acetoin as a Useful Byproduct from Soybean Milk and Glucose.

Authors:  Zijun Xiao; Jie Shen; Yang Li; Zhuo Wang; Yanshuang Zhao; Yong Chen; Jing-Yi Zhao
Journal:  Probiotics Antimicrob Proteins       Date:  2021-08-13       Impact factor: 5.265

Review 5.  Recent Advances in Nattokinase-Enriched Fermented Soybean Foods: A Review.

Authors:  Danfeng Li; Lizhen Hou; Miao Hu; Yaxin Gao; Zhiliang Tian; Bei Fan; Shuying Li; Fengzhong Wang
Journal:  Foods       Date:  2022-06-24

6.  Interactions between nattokinase and heparin/GAGs.

Authors:  Fuming Zhang; Jianhua Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2015-09-28       Impact factor: 2.916

7.  Molecular analysis of a fibrin-degrading enzyme from Bacillus subtilis K2 isolated from the Indonesian soybean-based fermented food moromi.

Authors:  Fathma Syahbanu; Puspo Edi Giriwono; Raymond R Tjandrawinata; Maggy T Suhartono
Journal:  Mol Biol Rep       Date:  2020-10-27       Impact factor: 2.316

8.  Strain Screening from Traditional Fermented Soybean Foods and Induction of Nattokinase Production in Bacillus subtilis MX-6.

Authors:  Li-Li Man; Dian-Jun Xiang; Chun-Lan Zhang
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

Review 9.  Exploitation of Bacillus subtilis as a robust workhorse for production of heterologous proteins and beyond.

Authors:  Wenjing Cui; Laichuang Han; Feiya Suo; Zhongmei Liu; Li Zhou; Zhemin Zhou
Journal:  World J Microbiol Biotechnol       Date:  2018-09-10       Impact factor: 3.312

10.  A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles.

Authors:  Yuko Kurosawa; Shinsuke Nirengi; Toshiyuki Homma; Kazuki Esaki; Mitsuhiro Ohta; Joseph F Clark; Takafumi Hamaoka
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.